SCOTT KUSCHMIDER

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HAS/FSA provisions. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HAS/FSA provisions. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HAS/FSA provisions. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HAS/FSA provisions. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to pollinator health and habitat promotion. Address administrative action related to pesticide registration and approval issues. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to the Pet and Womens Safety Act, as authorized in the 2018 Farm Bill. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act). H.R. 1337, Saving Americas Pollinators Act of 2019. H.R. 1783, Keep Food Safe from Glyphosate Act of 2019.

Monitor legislative and administrative action related to pollinator health and habitat promotion. Address administrative action related to pesticide registration and approval issues. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to the Pet and Womens Safety Act, as authorized in the 2018 Farm Bill. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act). H.R. 1337, Saving Americas Pollinators Act of 2019. H.R. 1783, Keep Food Safe from Glyphosate Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HAS/FSA provisions. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HAS/FSA provisions. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HAS/FSA provisions. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to pollinator health and habitat promotion. Address administrative action related to pesticide registration and approval issues. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to the Pet and Womens Safety Act, as authorized in the 2018 Farm Bill. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act). H.R. 1337, Saving Americas Pollinators Act of 2019. H.R. 1783, Keep Food Safe from Glyphosate Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HAS/FSA provisions. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to pollinator health and habitat promotion. Address administrative action related to pesticide registration and approval issues. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to the Pet and Womens Safety Act, as authorized in the 2018 Farm Bill. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act). H.R. 1337, Saving Americas Pollinators Act of 2019. H.R. 1783, Keep Food Safe from Glyphosate Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HAS/FSA provisions. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HAS/FSA provisions. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to trade. Monitor legislative and administrative action related to foreign regulation of chemicals and pesticides. Monitor legislative issues and administrative action related to trade discussions with China, including those related to the ag biotech sector and glyphosate. Monitor legislative and administrative action related to China import approvals. Monitor legislative and administrative action related to Mexico import approvals. Monitor legislative and administrative action related to EU import approvals and MRLs. Monitor legislative and administrative action related to maximum residue levels (MRLs) generally and within the context of the proposed EU-US FTA. Monitor legislative and administrative action related to foreign agriculture laws, regulations, and trade. Monitor legislative and administrative action related to investigation of Sections 232 and 301 of the Trade Act of 1974. Monitor legislative and administrative action related to the negotiation of the United States-Mexico-Canada Agreement (USMCA), including Mexico biotechnology and glyphosate import permits. Monitor legislative and administrative action related to the renegotiation of the United States-Korea Free Trade Agreement (KORUS FTA). Monitor administrative action related to the Review of Controls for Certain Emerging Technologies ANPRM. Monitor legislative and administrative action related to Venezuela sanctions. Monitor legislative and administrative action related to intellectual property issues and regulations in Brazil, India, and Ukraine. Monitor legislative and administrative action related to seed importation. S. 287, Bicameral Congressional Trade Authority Act of 2019. H.R. 940, Bicameral Congressional Trade Authority Act of 2019.

Monitor legislative and administrative action related to trade. Monitor legislative and administrative action related to foreign regulation of chemicals and pesticides. Monitor legislative issues and administrative action related to trade discussions with China, including those related to the ag biotech sector and glyphosate. Monitor legislative and administrative action related to China import approvals. Monitor legislative and administrative action related to Mexico import approvals. Monitor legislative and administrative action related to EU import approvals and MRLs. Monitor legislative and administrative action related to maximum residue levels (MRLs) generally and within the context of the proposed EU-US FTA. Monitor legislative and administrative action related to foreign agriculture laws, regulations, and trade. Monitor legislative and administrative action related to investigation of Sections 232 and 301 of the Trade Act of 1974. Monitor legislative and administrative action related to the negotiation of the United States-Mexico-Canada Agreement (USMCA), including Mexico biotechnology and glyphosate import permits. Monitor legislative and administrative action related to the renegotiation of the United States-Korea Free Trade Agreement (KORUS FTA). Monitor administrative action related to the Review of Controls for Certain Emerging Technologies ANPRM. Monitor legislative and administrative action related to Venezuela sanctions. Monitor legislative and administrative action related to intellectual property issues and regulations in Brazil, India, and Ukraine. Monitor legislative and administrative action related to seed importation. S. 287, Bicameral Congressional Trade Authority Act of 2019. H.R. 940, Bicameral Congressional Trade Authority Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HAS/FSA provisions. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HAS/FSA provisions. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HAS/FSA provisions. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HAS/FSA provisions. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HAS/FSA provisions. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HAS/FSA provisions. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to trade. Monitor legislative and administrative action related to foreign regulation of chemicals and pesticides. Monitor legislative issues and administrative action related to trade discussions with China, including those related to the ag biotech sector and glyphosate. Monitor legislative and administrative action related to China import approvals. Monitor legislative and administrative action related to Mexico import approvals. Monitor legislative and administrative action related to EU import approvals and MRLs. Monitor legislative and administrative action related to maximum residue levels (MRLs) generally and within the context of the proposed EU-US FTA. Monitor legislative and administrative action related to foreign agriculture laws, regulations, and trade. Monitor legislative and administrative action related to investigation of Sections 232 and 301 of the Trade Act of 1974. Monitor legislative and administrative action related to the negotiation of the United States-Mexico-Canada Agreement (USMCA), including Mexico biotechnology and glyphosate import permits. Monitor legislative and administrative action related to the renegotiation of the United States-Korea Free Trade Agreement (KORUS FTA). Monitor administrative action related to the Review of Controls for Certain Emerging Technologies ANPRM. Monitor legislative and administrative action related to Venezuela sanctions. Monitor legislative and administrative action related to intellectual property issues and regulations in Brazil, India, and Ukraine. Monitor legislative and administrative action related to seed importation. S. 287, Bicameral Congressional Trade Authority Act of 2019. H.R. 940, Bicameral Congressional Trade Authority Act of 2019.

Monitor legislative and administrative action related to trade. Monitor legislative and administrative action related to foreign regulation of chemicals and pesticides. Monitor legislative issues and administrative action related to trade discussions with China, including those related to the ag biotech sector and glyphosate. Monitor legislative and administrative action related to China import approvals. Monitor legislative and administrative action related to Mexico import approvals. Monitor legislative and administrative action related to EU import approvals and MRLs. Monitor legislative and administrative action related to maximum residue levels (MRLs) generally and within the context of the proposed EU-US FTA. Monitor legislative and administrative action related to foreign agriculture laws, regulations, and trade. Monitor legislative and administrative action related to investigation of Sections 232 and 301 of the Trade Act of 1974. Monitor legislative and administrative action related to the negotiation of the United States-Mexico-Canada Agreement (USMCA), including Mexico biotechnology and glyphosate import permits. Monitor legislative and administrative action related to the renegotiation of the United States-Korea Free Trade Agreement (KORUS FTA). Monitor administrative action related to the Review of Controls for Certain Emerging Technologies ANPRM. Monitor legislative and administrative action related to Venezuela sanctions. Monitor legislative and administrative action related to intellectual property issues and regulations in Brazil, India, and Ukraine. Monitor legislative and administrative action related to seed importation. S. 287, Bicameral Congressional Trade Authority Act of 2019. H.R. 940, Bicameral Congressional Trade Authority Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HAS/FSA provisions. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HAS/FSA provisions. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action on appropriations and budget. H.J. Res. 31, Consolidated Appropriations Act, 2019 (P.L. 116-6). H.J. Res 28, Further Additional Continuing Appropriations Act, 2019 (P.L. 116-5).

Monitor legislative and administrative action on appropriations and budget. H.J. Res. 31, Consolidated Appropriations Act, 2019 (P.L. 116-6). H.J. Res 28, Further Additional Continuing Appropriations Act, 2019 (P.L. 116-5).

Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to the Pet and Womens Safety Act, as authorized in the 2018 Farm Bill. S. 483, Pesticide Registration Improvement Extension Act of 2018, Public Law No: 116-8 (enacted into law H.R. 1029, 115th Congress, as passed by the Senate). H.R. 1337, Saving Americas Pollinators Act of 2019. H.R. 1783, Keep Food Safe from Glyphosate Act of 2019.

Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to the Pet and Womens Safety Act, as authorized in the 2018 Farm Bill. Communication on status of Bayer activities related to agricultural chemistries. H.R. 1337, Saving Americas Pollinators Act of 2019. H.R. 1783, Keep Food Safe from Glyphosate Act of 2019.

Monitor legislative and administrative action related to pollinator health and habitat promotion. Address administrative action related to pesticide registration and approval issues. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to the Pet and Womens Safety Act, as authorized in the 2018 Farm Bill. H.R. 1337, Saving Americas Pollinators Act of 2019. H.R. 1783, Keep Food Safe from Glyphosate Act of 2019.

Monitor legislative and administrative action related to pollinator health and habitat promotion. Address administrative action related to pesticide registration and approval issues. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to the Pet and Womens Safety Act, as authorized in the 2018 Farm Bill. H.R. 1337, Saving Americas Pollinators Act of 2019. H.R. 1783, Keep Food Safe from Glyphosate Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to repealing the medical device tax. Monitor legislative and administrative action related to sunscreen issues. Monitor legislative and administrative action related to P.L. 113-195, The Sunscreen Innovation Act. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to repealing the medical device tax. Monitor legislative and administrative action related to sunscreen issues. Monitor legislative and administrative action related to P.L. 113-195, The Sunscreen Innovation Act. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to repealing the medical device tax. Monitor legislative and administrative action related to sunscreen issues. Monitor legislative and administrative action related to P.L. 113-195, The Sunscreen Innovation Act. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to repealing the medical device tax. Monitor legislative and administrative action related to sunscreen issues. Monitor legislative and administrative action related to P.L. 113-195, The Sunscreen Innovation Act. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to repealing the medical device tax. Monitor legislative and administrative action related to sunscreen issues. Monitor legislative and administrative action related to P.L. 113-195, The Sunscreen Innovation Act. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to repealing the medical device tax. Monitor legislative and administrative action related to sunscreen issues. Monitor legislative and administrative action related to P.L. 113-195, The Sunscreen Innovation Act. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to repealing the medical device tax. Monitor legislative and administrative action related to sunscreen issues. Monitor legislative and administrative action related to P.L. 113-195, The Sunscreen Innovation Act. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to repealing the medical device tax. Monitor legislative and administrative action related to sunscreen issues. Monitor legislative and administrative action related to P.L. 113-195, The Sunscreen Innovation Act. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to repealing the medical device tax. Monitor legislative and administrative action related to sunscreen issues. Monitor legislative and administrative action related to P.L. 113-195, The Sunscreen Innovation Act. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019.

Monitor legislative and administrative action related to pollinator health and habitat promotion. Address administrative action related to pesticide registration and approval issues. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to the Pet and Womens Safety Act, as authorized in the 2018 Farm Bill. H.R. 1337, Saving Americas Pollinators Act of 2019. H.R. 1783, Keep Food Safe from Glyphosate Act of 2019.

Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to the Pet and Womens Safety Act, as authorized in the 2018 Farm Bill. Communication on status of Bayer activities related to agricultural chemistries. H.R. 1337, Saving Americas Pollinators Act of 2019. H.R. 1783, Keep Food Safe from Glyphosate Act of 2019.

Monitor legislative and administrative action related to pollinator health and habitat promotion. Address administrative action related to pesticide registration and approval issues. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to the Pet and Womens Safety Act, as authorized in the 2018 Farm Bill. H.R. 1337, Saving Americas Pollinators Act of 2019. H.R. 1783, Keep Food Safe from Glyphosate Act of 2019.

Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to the Pet and Womens Safety Act, as authorized in the 2018 Farm Bill. S. 483, Pesticide Registration Improvement Extension Act of 2018, Public Law No: 116-8 (enacted into law H.R. 1029, 115th Congress, as passed by the Senate). H.R. 1337, Saving Americas Pollinators Act of 2019. H.R. 1783, Keep Food Safe from Glyphosate Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to repealing the medical device tax. Monitor legislative and administrative action related to sunscreen issues. Monitor legislative and administrative action related to P.L. 113-195, The Sunscreen Innovation Act. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to repealing the medical device tax. Monitor legislative and administrative action related to sunscreen issues. Monitor legislative and administrative action related to P.L. 113-195, The Sunscreen Innovation Act. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to repealing the medical device tax. Monitor legislative and administrative action related to sunscreen issues. Monitor legislative and administrative action related to P.L. 113-195, The Sunscreen Innovation Act. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to repealing the medical device tax. Monitor legislative and administrative action related to sunscreen issues. Monitor legislative and administrative action related to P.L. 113-195, The Sunscreen Innovation Act. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to repealing the medical device tax. Monitor legislative and administrative action related to sunscreen issues. Monitor legislative and administrative action related to P.L. 113-195, The Sunscreen Innovation Act. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to repealing the medical device tax. Monitor legislative and administrative action related to sunscreen issues. Monitor legislative and administrative action related to P.L. 113-195, The Sunscreen Innovation Act. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to repealing the medical device tax. Monitor legislative and administrative action related to sunscreen issues. Monitor legislative and administrative action related to P.L. 113-195, The Sunscreen Innovation Act. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to repealing the medical device tax. Monitor legislative and administrative action related to sunscreen issues. Monitor legislative and administrative action related to P.L. 113-195, The Sunscreen Innovation Act. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to trade. Monitor legislative and administrative action related to foreign regulation of chemicals and pesticides. Monitor legislative issues and administrative action related to trade discussions with China, including those related to the ag biotech sector. Monitor legislative and administrative action related to China import approvals. Monitor legislative and administrative action related to EU import approvals and MRLs. Monitor legislative and administrative action related to foreign agriculture laws, regulations, and trade. Monitor legislative and administrative action related to investigation of Sections 232 and 301 of the Trade Act of 1974. Monitor legislative and administrative action related to the negotiation of the United States-Mexico-Canada Agreement (USMCA). Monitor legislative and administrative action related to the renegotiation of the United States-Korea Free Trade Agreement (KORUS FTA). Monitor administrative action related to the Review of Controls for Certain Emerging Technologies ANPRM. Monitor legislative and administrative action related to Venezuela sanctions. Monitor legislative and administrative action related to intellectual property issues and regulations in Brazil, India, and Ukraine. S. 287, Bicameral Congressional Trade Authority Act of 2019. H.R. 940, Bicameral Congressional Trade Authority Act of 2019.

Monitor legislative and administrative action related to trade. Monitor legislative and administrative action related to foreign regulation of chemicals and pesticides. Monitor legislative issues and administrative action related to trade discussions with China, including those related to the ag biotech sector. Monitor legislative and administrative action related to China import approvals. Monitor legislative and administrative action related to EU import approvals and MRLs. Monitor legislative and administrative action related to foreign agriculture laws, regulations, and trade. Monitor legislative and administrative action related to investigation of Sections 232 and 301 of the Trade Act of 1974. Monitor legislative and administrative action related to the negotiation of the United States-Mexico-Canada Agreement (USMCA). Monitor legislative and administrative action related to the renegotiation of the United States-Korea Free Trade Agreement (KORUS FTA). Monitor administrative action related to the Review of Controls for Certain Emerging Technologies ANPRM. Monitor legislative and administrative action related to Venezuela sanctions. Monitor legislative and administrative action related to intellectual property issues and regulations in Brazil, India, and Ukraine. Monitor legislative and administrative action related to seed importation. S. 287, Bicameral Congressional Trade Authority Act of 2019. H.R. 940, Bicameral Congressional Trade Authority Act of 2019.

Monitor legislative and administrative action related to trade. Monitor legislative and administrative action related to foreign regulation of chemicals and pesticides. Monitor legislative issues and administrative action related to trade discussions with China, including those related to the ag biotech sector. Monitor legislative and administrative action related to China import approvals. Monitor legislative and administrative action related to EU import approvals. Monitor legislative and administrative action related to foreign agriculture laws, regulations, and trade. Monitor legislative and administrative action related to investigation of Sections 232 and 301 of the Trade Act of 1974. Monitor legislative and administrative action related to the negotiation of the United States-Mexico-Canada Agreement (USMCA). Monitor legislative and administrative action related to the renegotiation of the United States-Korea Free Trade Agreement (KORUS FTA). Monitor administrative action related to the Review of Controls for Certain Emerging Technologies ANPRM. Monitor legislative and administrative action related to Venezuela sanctions. Monitor legislative and administrative action related to intellectual property issues and regulations in Brazil, India, and Ukraine. S. 287, Bicameral Congressional Trade Authority Act of 2019. H.R. 940, Bicameral Congressional Trade Authority Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to repealing the medical device tax. Monitor legislative and administrative action related to sunscreen issues. Monitor legislative and administrative action related to P.L. 113-195, The Sunscreen Innovation Act. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to repealing the medical device tax. Monitor legislative and administrative action related to sunscreen issues. Monitor legislative and administrative action related to P.L. 113-195, The Sunscreen Innovation Act. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to repealing the medical device tax. Monitor legislative and administrative action related to sunscreen issues. Monitor legislative and administrative action related to P.L. 113-195, The Sunscreen Innovation Act. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to repealing the medical device tax. Monitor legislative and administrative action related to sunscreen issues. Monitor legislative and administrative action related to P.L. 113-195, The Sunscreen Innovation Act. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to repealing the medical device tax. Monitor legislative and administrative action related to sunscreen issues. Monitor legislative and administrative action related to P.L. 113-195, The Sunscreen Innovation Act. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to repealing the medical device tax. Monitor legislative and administrative action related to sunscreen issues. Monitor legislative and administrative action related to P.L. 113-195, The Sunscreen Innovation Act. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to repealing the medical device tax. Monitor legislative and administrative action related to sunscreen issues. Monitor legislative and administrative action related to P.L. 113-195, The Sunscreen Innovation Act. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to repealing the medical device tax. Monitor legislative and administrative action related to sunscreen issues. Monitor legislative and administrative action related to P.L. 113-195, The Sunscreen Innovation Act. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to trade. Monitor legislative and administrative action related to foreign regulation of chemicals and pesticides. Monitor legislative issues and administrative action related to trade discussions with China, including those related to the ag biotech sector. Monitor legislative and administrative action related to China import approvals. Monitor legislative and administrative action related to EU import approvals. Monitor legislative and administrative action related to foreign agriculture laws, regulations, and trade. Monitor legislative and administrative action related to investigation of Sections 232 and 301 of the Trade Act of 1974. Monitor legislative and administrative action related to the negotiation of the United States-Mexico-Canada Agreement (USMCA). Monitor legislative and administrative action related to the renegotiation of the United States-Korea Free Trade Agreement (KORUS FTA). Monitor administrative action related to the Review of Controls for Certain Emerging Technologies ANPRM. Monitor legislative and administrative action related to Venezuela sanctions. Monitor legislative and administrative action related to intellectual property issues and regulations in Brazil, India, and Ukraine. S. 287, Bicameral Congressional Trade Authority Act of 2019. H.R. 940, Bicameral Congressional Trade Authority Act of 2019.

Monitor legislative and administrative action related to trade. Monitor legislative and administrative action related to foreign regulation of chemicals and pesticides. Monitor legislative issues and administrative action related to trade discussions with China, including those related to the ag biotech sector. Monitor legislative and administrative action related to China import approvals. Monitor legislative and administrative action related to EU import approvals and MRLs. Monitor legislative and administrative action related to foreign agriculture laws, regulations, and trade. Monitor legislative and administrative action related to investigation of Sections 232 and 301 of the Trade Act of 1974. Monitor legislative and administrative action related to the negotiation of the United States-Mexico-Canada Agreement (USMCA). Monitor legislative and administrative action related to the renegotiation of the United States-Korea Free Trade Agreement (KORUS FTA). Monitor administrative action related to the Review of Controls for Certain Emerging Technologies ANPRM. Monitor legislative and administrative action related to Venezuela sanctions. Monitor legislative and administrative action related to intellectual property issues and regulations in Brazil, India, and Ukraine. S. 287, Bicameral Congressional Trade Authority Act of 2019. H.R. 940, Bicameral Congressional Trade Authority Act of 2019.

Monitor legislative and administrative action related to trade. Monitor legislative and administrative action related to foreign regulation of chemicals and pesticides. Monitor legislative issues and administrative action related to trade discussions with China, including those related to the ag biotech sector. Monitor legislative and administrative action related to China import approvals. Monitor legislative and administrative action related to EU import approvals and MRLs. Monitor legislative and administrative action related to foreign agriculture laws, regulations, and trade. Monitor legislative and administrative action related to investigation of Sections 232 and 301 of the Trade Act of 1974. Monitor legislative and administrative action related to the negotiation of the United States-Mexico-Canada Agreement (USMCA). Monitor legislative and administrative action related to the renegotiation of the United States-Korea Free Trade Agreement (KORUS FTA). Monitor administrative action related to the Review of Controls for Certain Emerging Technologies ANPRM. Monitor legislative and administrative action related to Venezuela sanctions. Monitor legislative and administrative action related to intellectual property issues and regulations in Brazil, India, and Ukraine. Monitor legislative and administrative action related to seed importation. S. 287, Bicameral Congressional Trade Authority Act of 2019. H.R. 940, Bicameral Congressional Trade Authority Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to repealing the medical device tax. Monitor legislative and administrative action related to sunscreen issues. Monitor legislative and administrative action related to P.L. 113-195, The Sunscreen Innovation Act. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to repealing the medical device tax. Monitor legislative and administrative action related to sunscreen issues. Monitor legislative and administrative action related to P.L. 113-195, The Sunscreen Innovation Act. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to repealing the medical device tax. Monitor legislative and administrative action related to sunscreen issues. Monitor legislative and administrative action related to P.L. 113-195, The Sunscreen Innovation Act. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to the Pet and Womens Safety Act, as authorized in the 2018 Farm Bill. S. 483, Pesticide Registration Improvement Extension Act of 2018, Public Law No: 116-8 (enacted into law H.R. 1029, 115th Congress, as passed by the Senate). H.R. 1337, Saving Americas Pollinators Act of 2019. H.R. 1783, Keep Food Safe from Glyphosate Act of 2019.

Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to the Pet and Womens Safety Act, as authorized in the 2018 Farm Bill. S. 483, Pesticide Registration Improvement Extension Act of 2018, Public Law No: 116-8 (enacted into law H.R. 1029, 115th Congress, as passed by the Senate). H.R. 1337, Saving Americas Pollinators Act of 2019. H.R. 1783, Keep Food Safe from Glyphosate Act of 2019.